Original Research

Published on 30 Aug 2023

CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome

in Pharmacology of Anti-Cancer Drugs

Songyi Park
Sunghye Lee
Dongyeop Kim
Hyejeong Kim
Young-Guen Kwon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242970

920 views

Review

Published on 30 Aug 2023

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges

in Pharmacology of Anti-Cancer Drugs

Isha Bansal
Amit Kumar Pandey
Munindra Ruwali

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244597

2,008 views

Case Report

Published on 30 Aug 2023

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report

in Pharmacology of Anti-Cancer Drugs

Chan-Ran Park
Hye-Ri Bae
Ga-Young Lee
Chang-Gue Son
Jung-Hyo Cho
Chong-Kwan Cho
Nam-Hun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203379

869 views

Case Report

Published on 29 Aug 2023

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Haoyue Hu
Songtao Tan
Meng Xie
Peng Guo
Qiang Yu
Juan Xiao
Kangrui Zhao
Qiong Liao
Yi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167959

1,561 views

Case Report

Published on 29 Aug 2023

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Linlin Li
Siyuan Huang
Liying Qin
Ningning Yan
Shujing Shen
Xingya Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257592

1,223 views
1 citation

Original Research

Published on 28 Aug 2023

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease

in Pharmacology of Anti-Cancer Drugs

Xiao Li
Yong-Li Gu
Xu-Chao Liu
Zeng-Xian Sun
Ying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218480

868 views

Review

Published on 28 Aug 2023

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

in Pharmacology of Anti-Cancer Drugs

Huimin Zhou
Cong Zhao
Rongguang Shao
Yanni Xu
Wuli Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187741

2,189 views

Editorial

Published on 25 Aug 2023

Editorial: Adaptive immune resistance in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Aimin Jiang
Ouyang Chen
Zhigang Liu
Hongzhou Cai
Linhui Wang
Lin Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1277902

1,022 views

Original Research

Published on 24 Aug 2023

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness

in Pharmacology of Anti-Cancer Drugs

Sheng Tu
Yunqing Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1213506

757 views

Original Research

Published on 24 Aug 2023

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators

in Pharmacology of Anti-Cancer Drugs

Yang Liu
Yizhao Wang
Chang Li
Huijin Feng
Yanqing Liu
Lianjun Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1254918

1,051 views

Review

Published on 24 Aug 2023

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

in Pharmacology of Anti-Cancer Drugs

Lu Zhan
Fangting Su
Qiang Li
Yueqiang Wen
Feng Wei
Zhelin He
Xiaoyan Chen
Xiang Yin
Jian Wang
Yilin Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257450

2,440 views

Original Research

Published on 24 Aug 2023

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system

in Pharmacology of Anti-Cancer Drugs

Qiaona Wang
Yunshou Lin
Wenguan Yu
Xiaogang Chen
Qingqing He
Zhiyu Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228052

983 views

Case Report

Published on 22 Aug 2023

Case Report: Etoposide-nedaplatin induced rhabdomyolysis in a small cell lung cancer patient

in Pharmacology of Anti-Cancer Drugs

Xiaohu Xu
Xiao Wu
Mingmin Zhang
Qi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214149

1,001 views
1 citation

Editorial

Published on 22 Aug 2023

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer

in Pharmacology of Anti-Cancer Drugs

Liang Feng
Junfei Gu
Yanjun Yang
Bing Yang
Ruyu Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1251835

676 views
1 citation

Original Research

Published on 21 Aug 2023

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Chao Ma
Feng Li
Zhuoyu Gu
Yang Yang
Yu Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146840

2,159 views
1 citation

Review

Published on 21 Aug 2023

Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Haorui Zhang
Ping Luo
Xiaojun Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269224

872 views

Navigation group

Articles

CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

Editorial: Adaptive immune resistance in cancer therapy

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system

Case Report: Etoposide-nedaplatin induced rhabdomyolysis in a small cell lung cancer patient

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma

Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma